CORE SCIENTIFIC INC

Inside the insider sales of Core Scientific: 8,300 shares sold for $200k+ amid a pivot to AI‑driven data‑center services, AMD partnership, and disciplined trading plans.

Core Scientific insider selling: Todd DuChene’s July 20, 2026 10K‑share sale highlights systematic trading amid market volatility. Understand the impact on stock confidence and future growth potential.

Core Scientific insider sale sparks market buzz—explore how CEO liquidity moves and blockchain‑AI tech impact investors & cyber security.

Core Scientific insider sales reveal investor sentiment, but expert analysis shows how microservices, AI observability and hybrid cloud can unlock biotech growth.

Insightful insider sale by Todd M. Duchene at Core Scientific: 10 000+ shares off the table amid a 20% monthly gain, yet the AI‑blockchain partnership keeps bullish prospects alive.

Core Scientific’s insider sale under Rule 10b‑5‑1 shows a disciplined liquidity plan, not panic, yet adds volatility risk—read how governance, investor trust, and crypto‑security align.

Core Scientific’s CFO receives a 120,074‑RSU grant while senior executives sell shares—an insider strategy that balances short‑term liquidity with long‑term alignment, highlighting risks and AI‑driven monitoring tools for investors and IT security p…

Insider Duchene Todd M. sold 200k+ Core Scientific shares – a methodical rebalance amid AI‑mining hype. Discover what this signals for your portfolio.

Core Scientific’s new 37,998‑share RSU award for its Chief Accounting Officer signals management confidence amid AI‑driven growth, while recent insider sales hint at short‑term volatility—watch the vesting schedule and future insider activity.

Insider sale of Core Scientific shares amid a rally signals disciplined portfolio management, not weakness, and the company’s AI‑blockchain merger boosts long‑term growth potential.